| |
| |
|
| Insider
Information: |
Leavitt Chase C. |
| Relationship: |
General Counsel/Secret... |
| City: |
Alameda |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
89,758 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$33,638 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
89,758 |
|
|
| Total
Value |
$33,638 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
|
|
| Stock
price went down : |
|
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Lineage Cell Therapeutics Ord Shs |
LCTX |
General Counsel/Secret... |
2019-08-13 |
5,000 |
2019-08-13 |
0 |
Premium* |
|
|
Oncternal Therapeutics Inc |
ONCT |
General Counsel/Secret... |
2024-01-03 |
84,758 |
2021-06-11 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
11 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ONCT |
Oncternal Therapeutics In... |
General Counsel/Secretary |
• – – |
2024-01-03 |
4 |
D |
$0.50 |
$5,873 |
D/D |
(11,838) |
84,758 |
0 |
- |
|
| ONCT |
Oncternal Therapeutics In... |
General Counsel/Secretary |
• – – |
2023-07-03 |
4 |
D |
$0.36 |
$3,710 |
D/D |
(10,305) |
96,596 |
0 |
- |
|
| ONCT |
Oncternal Therapeutics In... |
General Counsel/Secretary |
• – – |
2023-04-13 |
4 |
B |
$0.29 |
$2,900 |
D/D |
10,000 |
106,901 |
2.66 |
% |
|
| ONCT |
Oncternal Therapeutics In... |
General Counsel/Secretary |
• – – |
2023-04-12 |
4 |
B |
$0.29 |
$4,350 |
D/D |
15,000 |
96,901 |
2.66 |
% |
|
| ONCT |
Oncternal Therapeutics In... |
General Counsel/Secretary |
• – – |
2023-01-03 |
4 |
D |
$1.02 |
$6,213 |
D/D |
(6,091) |
81,901 |
0 |
- |
|
| ONCT |
Oncternal Therapeutics In... |
General Counsel/Secretary |
• – – |
2022-07-28 |
4 |
A |
$0.00 |
$0 |
D/D |
43,125 |
87,992 |
0 |
- |
|
| ONCT |
Oncternal Therapeutics In... |
General Counsel/Secretary |
• – – |
2022-01-28 |
4 |
B |
$1.63 |
$8,150 |
D/D |
5,000 |
44,867 |
2.74 |
% |
|
| ONCT |
Oncternal Therapeutics In... |
General Counsel/Secretary |
• – – |
2022-01-27 |
4 |
B |
$1.78 |
$15,130 |
D/D |
8,500 |
39,867 |
2.74 |
% |
|
| ONCT |
Oncternal Therapeutics In... |
General Counsel/Secretary |
• – – |
2022-01-03 |
4 |
A |
$0.00 |
$0 |
D/D |
29,867 |
31,367 |
0 |
- |
|
| ONCT |
Oncternal Therapeutics In... |
General Counsel/Secretary |
• – – |
2021-06-11 |
4 |
B |
$5.45 |
$8,175 |
D/D |
1,500 |
1,500 |
2.74 |
% |
|
| LCTX |
Lineage Cell Therapeutics... |
General Counsel/Secretary |
• – – |
2019-08-13 |
4 |
B |
$1.02 |
$5,100 |
D/D |
5,000 |
5,000 |
2.74 |
- |
|
11 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
